相关实验视频

Updated: Jul 12, 2026

Using Quantitative Real-time PCR to Determine Donor Cell Engraftment in a Competitive Murine Bone Marrow Transplantation Model

Using Quantitative Real-time PCR to Determine Donor Cell Engraftment in a Competitive Murine Bone Marrow Transplantation Model

Published on: March 7, 2013

通过向单细胞突变分析来诊断受体与捐赠者衍生的移植后骨髓质瘤

Jana Ihlow¹, Livius Penter², Lam Giang Vuong³

¹Institute of Pathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Department of Hematology, Oncology and Cancer Immunology, Campus Virchow Clinic, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.

Med (New York, N.Y.)

|December 7, 2024

概括

在异性干细胞移植后确定骨髓质瘤 (MDS) 的起源至关重要. 单细胞分析确定了驱动MDS的受体衍生细胞,从而使个性化治疗决策成为可能.

科学领域:

血液学血液学血液学
在瘤学瘤学.
遗传学是一个遗传学.

背景情况:

在异性造血干细胞移植 (allo-HSCT) 后区分捐赠者与接受者衍生的骨髓质瘤 (MDS) 是临床上具有挑战性的.
移植后的MDS诊断具有重要的治疗意义.

研究的目的:

解决MDS的起源在一个患有获得的无塑性贫血和进化的MDS allo-HSCT后的患者.
为了区分捐赠者和接受者衍生的骨髓细胞,并确定MDS相关的突变.

主要方法:

使用一种翻译方法,将传统诊断与单细胞转录概况结合起来.
开发了一种用于识别具有U2AF1^S34Y变异的细胞的策略.
执行了针对U2AF1^S34Y特定位置的向丰富.

主要成果:

患者呈现出混合的捐赠者嵌合体,减少的红色素形成和失塑性变化.
单细胞剖析揭示了来自供体的免疫细胞,但主要来自受体的免疫细胞.
突变U2AF1^S34Y的细胞完全来自接受者,由X染色体特异性基因表达证实.

结论:

整合高分辨率单细胞技术可以解决复杂的移植后MDS病例.
这种方法有助于为患者做出个性化治疗决策.
强调了先进的分子技术在移植医学中的实用性.

关键词:

(U2AF1) ((S34Y) 的时间.在 MDS MDS 中.翻译给患者使用.所有的HSCT.没有无形性贫血.混合的奇幻主义.突变造型分析 (mutational profiling) 是一种针对突变的分析方法.个性化医疗是个性化的医疗.精准诊断精准诊断精准诊断精准诊断精准诊断一个单细胞的单细胞.有针对性的测序.

更多相关视频

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

相关概念视频

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...